Harvey A. Risch spends much of his time researching Internal medicine, Odds ratio, Cancer, Ovarian cancer and Case-control study. He has included themes like Gastroenterology, Endocrinology and Oncology in his Internal medicine study. The concepts of his Oncology study are interwoven with issues in Germline mutation, Relative risk, Breast cancer, Endometrial cancer and Genetic testing.
Harvey A. Risch combines subjects such as Genome-wide association study, Epidemiology, Incidence, Pancreatic cancer and Confidence interval with his study of Odds ratio. His research integrates issues of Cancer research, Gynecology, Serous fluid and Ovary in his study of Ovarian cancer. His Case-control study research focuses on Surgery and how it relates to Socioeconomic status, Pediatrics and Pooled analysis.
Harvey A. Risch mostly deals with Internal medicine, Oncology, Cancer, Ovarian cancer and Odds ratio. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Genome-wide association study. His studies deal with areas such as Carcinoma, Hazard ratio, Breast cancer, Single-nucleotide polymorphism and Endometrial cancer as well as Oncology.
His research in Cancer is mostly concerned with Prostate cancer. His study looks at the relationship between Ovarian cancer and fields such as Gynecology, as well as how they intersect with chemical problems. His study focuses on the intersection of Odds ratio and fields such as Confidence interval with connections in the field of Logistic regression.
His primary scientific interests are in Internal medicine, Oncology, Genome-wide association study, Pancreatic cancer and Genetic association. He regularly links together related areas like Mendelian Randomization Analysis in his Internal medicine studies. The various areas that Harvey A. Risch examines in his Oncology study include Quantitative trait locus, Breast cancer, Endometrial cancer and Hazard ratio.
His Genome-wide association study study incorporates themes from Transferrin, Cancer research and Ferritin. Harvey A. Risch has researched Ovarian cancer in several fields, including Odds ratio, Logistic regression and Depression. The study incorporates disciplines such as Absolute risk reduction, Barrett's esophagus and Risk factor in addition to Single-nucleotide polymorphism.
His primary areas of study are Internal medicine, Oncology, Genome-wide association study, Genetic association and Pandemic. Harvey A. Risch conducts interdisciplinary study in the fields of Internal medicine and Hydroxychloroquine through his research. His Oncology research is multidisciplinary, incorporating perspectives in Cancer, Breast cancer, Endometrial cancer, Biomarker and Cancer syndrome.
His Cancer research incorporates elements of Penetrance, Germline mutation, Exome and Allele frequency. His Genome-wide association study study integrates concerns from other disciplines, such as Ovarian cancer, Genetic correlation and Pancreatic cancer. His KRAS study combines topics from a wide range of disciplines, such as Odds ratio and Single-nucleotide polymorphism.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
A. Antoniou;P.D.P. Pharoah;S. Narod;H.A. Risch.
American Journal of Human Genetics (2003)
Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer
Harvey A. Risch;John R. McLaughlin;David E.C. Cole;Barry Rosen.
American Journal of Human Genetics (2001)
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms
Emad M El-Omar;Charles S Rabkin;Marilie D Gammon;Thomas L Vaughan.
Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.
Harvey A. Risch.
Journal of the National Cancer Institute (1999)
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.
Celeste Leigh Pearce;Claire Templeman;Mary Anne Rossing;Alice Lee.
Lancet Oncology (2012)
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)
Population attributable risks of esophageal and gastric cancers.
Lawrence S. Engel;Lawrence S. Engel;Wong Ho Chow;Thomas L. Vaughan;Marilie D. Gammon.
Journal of the National Cancer Institute (2003)
Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, Canada
Harvey A. Risch;John R. McLaughlin;David E. C. Cole;Barry Rosen.
Journal of the National Cancer Institute (2006)
Oral Contraceptives and the Risk of Hereditary Ovarian Cancer
Steven A. Narod;Harvey Risch;Roxana Moslehi;Anne Dørum.
The New England Journal of Medicine (1998)
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia.
Wong Ho Chow;William J. Blot;Thomas L. Vaughan;Harvey A. Risch.
Journal of the National Cancer Institute (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: